WatchGov

Virginia bills · 2026 Regular Session

Virginia SB 527

Pharmaceutical Substance Manufacturing Grant Fund; created.

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed House
  5. To Governor
  6. Became law

Sponsors

Summary

Official abstract published by the Virginia legislature· SUMMARY AS PASSED

Pharmaceutical Substance Manufacturing Grant Fund. Establishes the Pharmaceutical Substance Manufacturing Grant Fund to provide grant installment awards between July 1, 2026, and July 1, 2045, in an amount not to exceed $34 million per fiscal year and in an aggregate amount not to exceed $191,255,000, to a qualified company that (i) engages in the manufacture of pharmaceutical substances, (ii) executes a memorandum of understanding with the Commonwealth, and (iii) is expected to make a capital investment of at least $4 billion and create and maintain at least 500 new full-time jobs. This bill is identical to HB 1076.

Text versions

Roll-call votes

State vote data last updated Oct 15, 2026, 8:04 PM.

DateVoteResultYour legislators
Mar 2, 2026
House		H VOTE:passSet your home in Virginia to see
Feb 25, 2026
House		Reported from AppropriationspassSet your home in Virginia to see
Feb 13, 2026
Senate		Passage RpassSet your home in Virginia to see
Feb 11, 2026
Senate		Constitutional reading dispensed RpassSet your home in Virginia to see
Feb 10, 2026
Senate		Reported from Finance and AppropriationspassSet your home in Virginia to see
Feb 2, 2026
Senate		Rereferred from Commerce and LaborpassSet your home in Virginia to see
Jan 22, 2026
Senate		Rereferred from Education and HealthpassSet your home in Virginia to see

Actions